ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nifedipine API Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-9F12478
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Nifedipine API Market Research Report 2022
BUY CHAPTERS

Global Nifedipine API Market Research Report 2025

Code: QYRE-Auto-9F12478
Report
March 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Dipharma Francis
Yantai Luyin Pharmaceutical
Delmar Chemicals Inc
Cipla Ltd
Teva Pharmaceuticals
Bayer
Moehs Iberica S.L.
Xiyue Pharmaceutical
Zhong'an Pharmaceutical
Siyao Pharmaceuticals
Qingyang Pharmaceutical
Sumika Fine Chemicals Co. Ltd.
Tecoland Corp

Nifedipine API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nifedipine API Market

Nifedipine API Market

The global market for Nifedipine API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nifedipine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nifedipine API.
The Nifedipine API market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nifedipine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nifedipine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nifedipine API Market Report

Report Metric Details
Report Name Nifedipine API Market
CAGR 5%
Segment by Type
  • 98% Nifedipine API
  • 99% Nifedipine API
  • 99.9% Nifedipine API
Segment by Application
  • Nifedipine Controlled Release Tablets
  • Nifedipine Extended Release Tablets
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dipharma Francis S.r.l, Yantai Luyin Pharmaceutical, Delmar Chemicals Inc., Cipla Ltd, Xiyue Pharmaceutical, Teva Pharmaceuticals, Zhong'an Pharmaceutical, Siyao Pharmaceuticals, Qingyang Pharmaceutical, Bayer AG, Sumika Fine Chemicals Co. Ltd., Tecoland Corp, Moehs Iberica S.L.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nifedipine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nifedipine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Nifedipine API Market report?

Ans: The main players in the Nifedipine API Market are Dipharma Francis S.r.l, Yantai Luyin Pharmaceutical, Delmar Chemicals Inc., Cipla Ltd, Xiyue Pharmaceutical, Teva Pharmaceuticals, Zhong'an Pharmaceutical, Siyao Pharmaceuticals, Qingyang Pharmaceutical, Bayer AG, Sumika Fine Chemicals Co. Ltd., Tecoland Corp, Moehs Iberica S.L.

What are the Application segmentation covered in the Nifedipine API Market report?

Ans: The Applications covered in the Nifedipine API Market report are Nifedipine Controlled Release Tablets, Nifedipine Extended Release Tablets

What are the Type segmentation covered in the Nifedipine API Market report?

Ans: The Types covered in the Nifedipine API Market report are 98% Nifedipine API, 99% Nifedipine API, 99.9% Nifedipine API

1 Nifedipine API Market Overview
1.1 Product Definition
1.2 Nifedipine API by Type
1.2.1 Global Nifedipine API Market Value Comparison by Type (2024 VS 2031)
1.2.2 98% Nifedipine API
1.2.3 99% Nifedipine API
1.2.4 99.9% Nifedipine API
1.3 Nifedipine API by Application
1.3.1 Global Nifedipine API Market Value by Application (2024 VS 2031)
1.3.2 Nifedipine Controlled Release Tablets
1.3.3 Nifedipine Extended Release Tablets
1.4 Global Nifedipine API Market Size Estimates and Forecasts
1.4.1 Global Nifedipine API Revenue 2020-2031
1.4.2 Global Nifedipine API Sales 2020-2031
1.4.3 Global Nifedipine API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nifedipine API Market Competition by Manufacturers
2.1 Global Nifedipine API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nifedipine API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nifedipine API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nifedipine API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nifedipine API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nifedipine API, Product Type & Application
2.7 Global Key Manufacturers of Nifedipine API, Date of Enter into This Industry
2.8 Global Nifedipine API Market Competitive Situation and Trends
2.8.1 Global Nifedipine API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nifedipine API Players Market Share by Revenue
2.8.3 Global Nifedipine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nifedipine API Market Scenario by Region
3.1 Global Nifedipine API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nifedipine API Sales by Region: 2020-2031
3.2.1 Global Nifedipine API Sales by Region: 2020-2025
3.2.2 Global Nifedipine API Sales by Region: 2026-2031
3.3 Global Nifedipine API Revenue by Region: 2020-2031
3.3.1 Global Nifedipine API Revenue by Region: 2020-2025
3.3.2 Global Nifedipine API Revenue by Region: 2026-2031
3.4 North America Nifedipine API Market Facts & Figures by Country
3.4.1 North America Nifedipine API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nifedipine API Sales by Country (2020-2031)
3.4.3 North America Nifedipine API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nifedipine API Market Facts & Figures by Country
3.5.1 Europe Nifedipine API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nifedipine API Sales by Country (2020-2031)
3.5.3 Europe Nifedipine API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nifedipine API Market Facts & Figures by Region
3.6.1 Asia Pacific Nifedipine API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nifedipine API Sales by Region (2020-2031)
3.6.3 Asia Pacific Nifedipine API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nifedipine API Market Facts & Figures by Country
3.7.1 Latin America Nifedipine API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nifedipine API Sales by Country (2020-2031)
3.7.3 Latin America Nifedipine API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nifedipine API Market Facts & Figures by Country
3.8.1 Middle East and Africa Nifedipine API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nifedipine API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nifedipine API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nifedipine API Sales by Type (2020-2031)
4.1.1 Global Nifedipine API Sales by Type (2020-2025)
4.1.2 Global Nifedipine API Sales by Type (2026-2031)
4.1.3 Global Nifedipine API Sales Market Share by Type (2020-2031)
4.2 Global Nifedipine API Revenue by Type (2020-2031)
4.2.1 Global Nifedipine API Revenue by Type (2020-2025)
4.2.2 Global Nifedipine API Revenue by Type (2026-2031)
4.2.3 Global Nifedipine API Revenue Market Share by Type (2020-2031)
4.3 Global Nifedipine API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nifedipine API Sales by Application (2020-2031)
5.1.1 Global Nifedipine API Sales by Application (2020-2025)
5.1.2 Global Nifedipine API Sales by Application (2026-2031)
5.1.3 Global Nifedipine API Sales Market Share by Application (2020-2031)
5.2 Global Nifedipine API Revenue by Application (2020-2031)
5.2.1 Global Nifedipine API Revenue by Application (2020-2025)
5.2.2 Global Nifedipine API Revenue by Application (2026-2031)
5.2.3 Global Nifedipine API Revenue Market Share by Application (2020-2031)
5.3 Global Nifedipine API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dipharma Francis S.r.l
6.1.1 Dipharma Francis S.r.l Company Information
6.1.2 Dipharma Francis S.r.l Description and Business Overview
6.1.3 Dipharma Francis S.r.l Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dipharma Francis S.r.l Nifedipine API Product Portfolio
6.1.5 Dipharma Francis S.r.l Recent Developments/Updates
6.2 Yantai Luyin Pharmaceutical
6.2.1 Yantai Luyin Pharmaceutical Company Information
6.2.2 Yantai Luyin Pharmaceutical Description and Business Overview
6.2.3 Yantai Luyin Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yantai Luyin Pharmaceutical Nifedipine API Product Portfolio
6.2.5 Yantai Luyin Pharmaceutical Recent Developments/Updates
6.3 Delmar Chemicals Inc.
6.3.1 Delmar Chemicals Inc. Company Information
6.3.2 Delmar Chemicals Inc. Description and Business Overview
6.3.3 Delmar Chemicals Inc. Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Delmar Chemicals Inc. Nifedipine API Product Portfolio
6.3.5 Delmar Chemicals Inc. Recent Developments/Updates
6.4 Cipla Ltd
6.4.1 Cipla Ltd Company Information
6.4.2 Cipla Ltd Description and Business Overview
6.4.3 Cipla Ltd Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Ltd Nifedipine API Product Portfolio
6.4.5 Cipla Ltd Recent Developments/Updates
6.5 Xiyue Pharmaceutical
6.5.1 Xiyue Pharmaceutical Company Information
6.5.2 Xiyue Pharmaceutical Description and Business Overview
6.5.3 Xiyue Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Xiyue Pharmaceutical Nifedipine API Product Portfolio
6.5.5 Xiyue Pharmaceutical Recent Developments/Updates
6.6 Teva Pharmaceuticals
6.6.1 Teva Pharmaceuticals Company Information
6.6.2 Teva Pharmaceuticals Description and Business Overview
6.6.3 Teva Pharmaceuticals Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceuticals Nifedipine API Product Portfolio
6.6.5 Teva Pharmaceuticals Recent Developments/Updates
6.7 Zhong'an Pharmaceutical
6.7.1 Zhong'an Pharmaceutical Company Information
6.7.2 Zhong'an Pharmaceutical Description and Business Overview
6.7.3 Zhong'an Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zhong'an Pharmaceutical Nifedipine API Product Portfolio
6.7.5 Zhong'an Pharmaceutical Recent Developments/Updates
6.8 Siyao Pharmaceuticals
6.8.1 Siyao Pharmaceuticals Company Information
6.8.2 Siyao Pharmaceuticals Description and Business Overview
6.8.3 Siyao Pharmaceuticals Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Siyao Pharmaceuticals Nifedipine API Product Portfolio
6.8.5 Siyao Pharmaceuticals Recent Developments/Updates
6.9 Qingyang Pharmaceutical
6.9.1 Qingyang Pharmaceutical Company Information
6.9.2 Qingyang Pharmaceutical Description and Business Overview
6.9.3 Qingyang Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Qingyang Pharmaceutical Nifedipine API Product Portfolio
6.9.5 Qingyang Pharmaceutical Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Company Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer AG Nifedipine API Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 Sumika Fine Chemicals Co. Ltd.
6.11.1 Sumika Fine Chemicals Co. Ltd. Company Information
6.11.2 Sumika Fine Chemicals Co. Ltd. Description and Business Overview
6.11.3 Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sumika Fine Chemicals Co. Ltd. Nifedipine API Product Portfolio
6.11.5 Sumika Fine Chemicals Co. Ltd. Recent Developments/Updates
6.12 Tecoland Corp
6.12.1 Tecoland Corp Company Information
6.12.2 Tecoland Corp Description and Business Overview
6.12.3 Tecoland Corp Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tecoland Corp Nifedipine API Product Portfolio
6.12.5 Tecoland Corp Recent Developments/Updates
6.13 Moehs Iberica S.L.
6.13.1 Moehs Iberica S.L. Company Information
6.13.2 Moehs Iberica S.L. Description and Business Overview
6.13.3 Moehs Iberica S.L. Nifedipine API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Moehs Iberica S.L. Nifedipine API Product Portfolio
6.13.5 Moehs Iberica S.L. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nifedipine API Industry Chain Analysis
7.2 Nifedipine API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nifedipine API Production Mode & Process Analysis
7.4 Nifedipine API Sales and Marketing
7.4.1 Nifedipine API Sales Channels
7.4.2 Nifedipine API Distributors
7.5 Nifedipine API Customer Analysis
8 Nifedipine API Market Dynamics
8.1 Nifedipine API Industry Trends
8.2 Nifedipine API Market Drivers
8.3 Nifedipine API Market Challenges
8.4 Nifedipine API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Dipharma Francis
Yantai Luyin Pharmaceutical
Delmar Chemicals Inc
Cipla Ltd
Teva Pharmaceuticals
Bayer
Moehs Iberica S.L.
Xiyue Pharmaceutical
Zhong'an Pharmaceutical
Siyao Pharmaceuticals
Qingyang Pharmaceutical
Sumika Fine Chemicals Co. Ltd.
Tecoland Corp
List of Tables
 Table 1. Global Nifedipine API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nifedipine API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nifedipine API Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nifedipine API Sales (K Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Nifedipine API Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nifedipine API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nifedipine API Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nifedipine API Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nifedipine API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nifedipine API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nifedipine API, Product Type & Application
 Table 12. Global Key Manufacturers of Nifedipine API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nifedipine API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nifedipine API as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nifedipine API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nifedipine API Sales by Region (2020-2025) & (K Tons)
 Table 18. Global Nifedipine API Sales Market Share by Region (2020-2025)
 Table 19. Global Nifedipine API Sales by Region (2026-2031) & (K Tons)
 Table 20. Global Nifedipine API Sales Market Share by Region (2026-2031)
 Table 21. Global Nifedipine API Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nifedipine API Revenue Market Share by Region (2020-2025)
 Table 23. Global Nifedipine API Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nifedipine API Revenue Market Share by Region (2026-2031)
 Table 25. North America Nifedipine API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nifedipine API Sales by Country (2020-2025) & (K Tons)
 Table 27. North America Nifedipine API Sales by Country (2026-2031) & (K Tons)
 Table 28. North America Nifedipine API Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nifedipine API Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nifedipine API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nifedipine API Sales by Country (2020-2025) & (K Tons)
 Table 32. Europe Nifedipine API Sales by Country (2026-2031) & (K Tons)
 Table 33. Europe Nifedipine API Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nifedipine API Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nifedipine API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nifedipine API Sales by Region (2020-2025) & (K Tons)
 Table 37. Asia Pacific Nifedipine API Sales by Region (2026-2031) & (K Tons)
 Table 38. Asia Pacific Nifedipine API Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nifedipine API Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nifedipine API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nifedipine API Sales by Country (2020-2025) & (K Tons)
 Table 42. Latin America Nifedipine API Sales by Country (2026-2031) & (K Tons)
 Table 43. Latin America Nifedipine API Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nifedipine API Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nifedipine API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nifedipine API Sales by Country (2020-2025) & (K Tons)
 Table 47. Middle East and Africa Nifedipine API Sales by Country (2026-2031) & (K Tons)
 Table 48. Middle East and Africa Nifedipine API Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nifedipine API Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nifedipine API Sales (K Tons) by Type (2020-2025)
 Table 51. Global Nifedipine API Sales (K Tons) by Type (2026-2031)
 Table 52. Global Nifedipine API Sales Market Share by Type (2020-2025)
 Table 53. Global Nifedipine API Sales Market Share by Type (2026-2031)
 Table 54. Global Nifedipine API Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nifedipine API Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nifedipine API Revenue Market Share by Type (2020-2025)
 Table 57. Global Nifedipine API Revenue Market Share by Type (2026-2031)
 Table 58. Global Nifedipine API Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Nifedipine API Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Nifedipine API Sales (K Tons) by Application (2020-2025)
 Table 61. Global Nifedipine API Sales (K Tons) by Application (2026-2031)
 Table 62. Global Nifedipine API Sales Market Share by Application (2020-2025)
 Table 63. Global Nifedipine API Sales Market Share by Application (2026-2031)
 Table 64. Global Nifedipine API Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nifedipine API Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nifedipine API Revenue Market Share by Application (2020-2025)
 Table 67. Global Nifedipine API Revenue Market Share by Application (2026-2031)
 Table 68. Global Nifedipine API Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Nifedipine API Price (US$/Ton) by Application (2026-2031)
 Table 70. Dipharma Francis S.r.l Company Information
 Table 71. Dipharma Francis S.r.l Description and Business Overview
 Table 72. Dipharma Francis S.r.l Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Dipharma Francis S.r.l Nifedipine API Product
 Table 74. Dipharma Francis S.r.l Recent Developments/Updates
 Table 75. Yantai Luyin Pharmaceutical Company Information
 Table 76. Yantai Luyin Pharmaceutical Description and Business Overview
 Table 77. Yantai Luyin Pharmaceutical Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Yantai Luyin Pharmaceutical Nifedipine API Product
 Table 79. Yantai Luyin Pharmaceutical Recent Developments/Updates
 Table 80. Delmar Chemicals Inc. Company Information
 Table 81. Delmar Chemicals Inc. Description and Business Overview
 Table 82. Delmar Chemicals Inc. Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Delmar Chemicals Inc. Nifedipine API Product
 Table 84. Delmar Chemicals Inc. Recent Developments/Updates
 Table 85. Cipla Ltd Company Information
 Table 86. Cipla Ltd Description and Business Overview
 Table 87. Cipla Ltd Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Cipla Ltd Nifedipine API Product
 Table 89. Cipla Ltd Recent Developments/Updates
 Table 90. Xiyue Pharmaceutical Company Information
 Table 91. Xiyue Pharmaceutical Description and Business Overview
 Table 92. Xiyue Pharmaceutical Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Xiyue Pharmaceutical Nifedipine API Product
 Table 94. Xiyue Pharmaceutical Recent Developments/Updates
 Table 95. Teva Pharmaceuticals Company Information
 Table 96. Teva Pharmaceuticals Description and Business Overview
 Table 97. Teva Pharmaceuticals Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Teva Pharmaceuticals Nifedipine API Product
 Table 99. Teva Pharmaceuticals Recent Developments/Updates
 Table 100. Zhong'an Pharmaceutical Company Information
 Table 101. Zhong'an Pharmaceutical Description and Business Overview
 Table 102. Zhong'an Pharmaceutical Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Zhong'an Pharmaceutical Nifedipine API Product
 Table 104. Zhong'an Pharmaceutical Recent Developments/Updates
 Table 105. Siyao Pharmaceuticals Company Information
 Table 106. Siyao Pharmaceuticals Description and Business Overview
 Table 107. Siyao Pharmaceuticals Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Siyao Pharmaceuticals Nifedipine API Product
 Table 109. Siyao Pharmaceuticals Recent Developments/Updates
 Table 110. Qingyang Pharmaceutical Company Information
 Table 111. Qingyang Pharmaceutical Description and Business Overview
 Table 112. Qingyang Pharmaceutical Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Qingyang Pharmaceutical Nifedipine API Product
 Table 114. Qingyang Pharmaceutical Recent Developments/Updates
 Table 115. Bayer AG Company Information
 Table 116. Bayer AG Description and Business Overview
 Table 117. Bayer AG Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Bayer AG Nifedipine API Product
 Table 119. Bayer AG Recent Developments/Updates
 Table 120. Sumika Fine Chemicals Co. Ltd. Company Information
 Table 121. Sumika Fine Chemicals Co. Ltd. Description and Business Overview
 Table 122. Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Sumika Fine Chemicals Co. Ltd. Nifedipine API Product
 Table 124. Sumika Fine Chemicals Co. Ltd. Recent Developments/Updates
 Table 125. Tecoland Corp Company Information
 Table 126. Tecoland Corp Description and Business Overview
 Table 127. Tecoland Corp Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Tecoland Corp Nifedipine API Product
 Table 129. Tecoland Corp Recent Developments/Updates
 Table 130. Moehs Iberica S.L. Company Information
 Table 131. Moehs Iberica S.L. Description and Business Overview
 Table 132. Moehs Iberica S.L. Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Moehs Iberica S.L. Nifedipine API Product
 Table 134. Moehs Iberica S.L. Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Nifedipine API Distributors List
 Table 138. Nifedipine API Customers List
 Table 139. Nifedipine API Market Trends
 Table 140. Nifedipine API Market Drivers
 Table 141. Nifedipine API Market Challenges
 Table 142. Nifedipine API Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nifedipine API
 Figure 2. Global Nifedipine API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nifedipine API Market Share by Type: 2024 & 2031
 Figure 4. 98% Nifedipine API Product Picture
 Figure 5. 99% Nifedipine API Product Picture
 Figure 6. 99.9% Nifedipine API Product Picture
 Figure 7. Global Nifedipine API Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Nifedipine API Market Share by Application: 2024 & 2031
 Figure 9. Nifedipine Controlled Release Tablets
 Figure 10. Nifedipine Extended Release Tablets
 Figure 11. Global Nifedipine API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Nifedipine API Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Nifedipine API Sales (2020-2031) & (K Tons)
 Figure 14. Global Nifedipine API Average Price (US$/Ton) & (2020-2031)
 Figure 15. Nifedipine API Report Years Considered
 Figure 16. Nifedipine API Sales Share by Manufacturers in 2024
 Figure 17. Global Nifedipine API Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Nifedipine API Players: Market Share by Revenue in Nifedipine API in 2024
 Figure 19. Nifedipine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Nifedipine API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Nifedipine API Sales Market Share by Country (2020-2031)
 Figure 22. North America Nifedipine API Revenue Market Share by Country (2020-2031)
 Figure 23. United States Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Nifedipine API Sales Market Share by Country (2020-2031)
 Figure 26. Europe Nifedipine API Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Nifedipine API Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Nifedipine API Revenue Market Share by Region (2020-2031)
 Figure 34. China Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Nifedipine API Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Nifedipine API Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Nifedipine API Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Nifedipine API Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Nifedipine API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Nifedipine API by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Nifedipine API by Type (2020-2031)
 Figure 55. Global Nifedipine API Price (US$/Ton) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Nifedipine API by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Nifedipine API by Application (2020-2031)
 Figure 58. Global Nifedipine API Price (US$/Ton) by Application (2020-2031)
 Figure 59. Nifedipine API Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions